InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Discover the detailed record of transactions filed by Pfeffer Cary, Director. Insider active across 1 companies, notably Jounce Therapeutics, Inc.. Aggregated, 6 reports have been logged. The latest transaction was disclosed on 12 November 2021 — Cession. Regulator: SEC (Form 4). All data is free.
Declarations6 total
0
Common Stock
SEC:0000899243-21-044914·
0
Common Stock
SEC:0000899243-21-044914:0·
0
Common Stock
SEC:0000899243-21-036399·
0
Common Stock
SEC:0000899243-21-036399:0·
0
Common Stock
SEC:0000899243-21-023559·
0
Common Stock
SEC:0000899243-21-023559:0·
6 of 6 declarations
About Pfeffer Cary
Cary Pfeffer is a Board Member at Jounce Therapeutics, Inc. He brings expertise in biotechnology and product development. His role involves guiding the company's direction and ensuring that strategic decisions align with growth objectives.
